In the last trading session, 2.51 million Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares changed hands as the company’s beta touched 1.75. With the company’s per share price at $28.00 changed hands at $4.9 or 21.21% during last session, the market valuation stood at $205.09M. TNXP’s last price was a discount, traded about -2300.0% off its 52-week high of $672.00. The share price had its 52-week low at $6.76, which suggests the last value was 75.86% up since then.
Analysts gave the Tonix Pharmaceuticals Holding Corp (TNXP) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended TNXP as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
Instantly TNXP was in green as seen at the end of in last trading. With action 48.70%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -15.10%, with the 5-day performance at 48.70% in the green. However, in the 30-day time frame, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is 76.54% up.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 46.06%. The 2025 estimates are for Tonix Pharmaceuticals Holding Corp earnings to increase by 92.98%.
TNXP Dividends
Tonix Pharmaceuticals Holding Corp is expected to release its next quarterly earnings report in June.
Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Total Market Index Fund . With 31.04 shares estimated at $0.87 million under it, the former controlled 0.42% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Total Market Index Fund held about 0.14% of the shares, roughly 10.5 shares worth around $0.29 million.
